Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Equity: 2017-2024

Historic Return on Equity for Akebia Therapeutics (AKBA) over the last 8 years, with Dec 2024 value amounting to 1.74%.

  • Akebia Therapeutics' Return on Equity fell 154.00% to -0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.45%, marking a year-over-year decrease of 154.00%. This contributed to the annual value of 1.74% for FY2024, which is 236.00% down from last year.
  • Latest data reveals that Akebia Therapeutics reported Return on Equity of 1.74% as of FY2024, which was down 57.51% from 4.10% recorded in FY2023.
  • Akebia Therapeutics' Return on Equity's 5-year high stood at 4.10% during FY2023, with a 5-year trough of -2.38% in FY2022.
  • For the 3-year period, Akebia Therapeutics' Return on Equity averaged around 1.15%, with its median value being 1.74% (2024).
  • In the last 5 years, Akebia Therapeutics' Return on Equity soared by 647bps in 2023 and then slumped by 236bps in 2024.
  • Akebia Therapeutics' Return on Equity (Yearly) stood at -1.20% in 2020, then slumped by 57bps to -1.77% in 2021, then slumped by 61bps to -2.38% in 2022, then skyrocketed by 647bps to 4.10% in 2023, then crashed by 236bps to 1.74% in 2024.